TSAI PHILIP (Chief Technology Officer) purchased 30.0% of their position (10K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $204.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/22/2025ACC: 0002026600-25-000004
Officer· Chief Technology Officer
Since Jun 2024
+10K
Net shares
Net buyer
$204.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$20.49
Trade value
$204.90K
% of position
30.0%
12/19/2025
33.30K→43.30K
Total
Net shares
+10K
Net value
$204.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | P · Purchase | +10K | $20.49 | $204.90K | 30.0% | 33.30K | 43.30K |
| Total | +10K | $204.90K | ||||||
Derivative Transactions0
No derivative transactions reported